OHSU Knight Cancer Institute, Tualatin is a clinical research site located in Tualatin, Oregon, United States 97062.
Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.
OHSU Knight Cancer Institute, Tualatin has participated in 3 clinical trials with 3 currently active.
Therapeutic areas: Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Exocrine Pancreatic Cancer.
Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Oregon · View every site in Tualatin
Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
OHSU Knight Cancer Institute, Tualatin has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
OHSU Knight Cancer Institute, Tualatin has 3 clinical trials on record, with 3 currently active. Their work covers Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Exocrine Pancreatic Cancer.
OHSU Knight Cancer Institute, Tualatin has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.